• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number D134805
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Cardiac Arrest (1762); Tachycardia (2095)
Event Date 02/25/2022
Event Type  Injury  
Event Description
It was reported that an unknown male patient underwent a ventricular tachycardia.(vt) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered cardiac arrest requiring resuscitation, surgical intervention, and prolonged hospitalization.It was reported that since the origin of vt was inferred to be epicardium (epi) by the surface electrocardiogram (ecg), ablation was performed by epicardium approach.Although coronary angiogram (cag) was performed, there was a tendency toward spasm overall, and blood pressure was low, 70 mmhg from the time of admission.The patients¿ blood pressure sometimes dropped to 30 mmhg without using a vasopressor, therefore blood pressure was maintained with a vasopressor.A sheath was introduced into the epi, and map was performed using the decanav, and an anomalous electrical potential was found below the right coronary artery (rca).When it was looked at the isochronal, the color was blocked, so ablation was conducted with stsf on the surface.The output was 30 w, the ai was aimed at 500, and the cf was approximately 10 g or less during ablation.During ablation, blood pressure decreased to 20 mmhg and vt occurred.Cardiac arrest occurred thereafter.Defibrillation (dc) was performed from the body surface, but vt did not stop.It was unknown whether it was pacing rhythm from the icd or not, so dc was performed, but as a result, the pulse disappeared, and resuscitative measures were taken.This occurred about 30 minutes since the stsf was used.An intra-aortic balloon pump (iabp) and percutaneous cardiopulmonary support (pcps) were inserted, and the patient left the room.Contact force was monitored by dashboard, vector, and visitag.Color setting of visitag was tag index.Additional filter was fot.The physician commented that it was not related to product.The patient¿s medical history: icd had been inserted and vt had often been seen at the ward but vt was not stopped by icd.Therefore, ablation was performed for the vt.The physician¿s opinion on the cause of this adverse event is that it is not related with the bwi product malfunction.The patient outcome of the adverse event improved.The patient did require extended hospitalization because of the adverse event, details are unknown.Other relevant history includes icd, and vt that occurred frequently in the ward.However, it did not stop with icd and decided to conduct ablation.A smartablate generator was used, no serving is needed for it.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious and mdr-reportable.
 
Manufacturer Narrative
Initial reporter phone: (b)(6).The bwi product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
On 4-apr-2022, bwi received additional information regarding the event.It was reported that a 74-year-old male patient (66kg) underwent a ventricular tachycardia.The physician¿s opinion on the cause of this adverse event was not related with the bwi product malfunction.The patient outcome of the adverse event improved.The patient did require extended hospitalization because of the adverse event.There was an icd, and vt occurred frequently in the ward.However, it did not stop with icd and decided to conduct abl.The generator was a smartablate and it does not need service.Additionally, the product investigation was completed on 21-apr-2022.Device evaluation details: visual analysis revealed no damage or anomalies on the device.Per the event, several tests were performed.The magnetic, temperature, and force features were tested and no issues were observed.In addition, the product was deflecting and irrigating correctly.No malfunctions were observed during the product analysis.A manufacturing record evaluation was performed for the finished device 30694181l number, and no internal action was found during the review.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The ifu (instruction for use) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key13837760
MDR Text Key290783899
Report Number2029046-2022-00584
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010183
UDI-Public10846835010183
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/09/2022
Device Model NumberD134805
Device Catalogue NumberD134805
Device Lot Number30694181L
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/16/2022
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/25/2022
Initial Date FDA Received03/21/2022
Supplement Dates Manufacturer Received04/04/2022
Supplement Dates FDA Received04/26/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured12/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTO 3 SYSTEM.; DECANAV CATHETER.; SMARTABLATE GENERATOR.; SOUNDSTAR ECO CATHETER.; VISITAG MODULE.
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention;
Patient Age74 YR
Patient SexMale
Patient Weight66 KG
-
-